RU2198876C2 - Производные пропаноламина, способы их получения и средство на их основе - Google Patents

Производные пропаноламина, способы их получения и средство на их основе Download PDF

Info

Publication number
RU2198876C2
RU2198876C2 RU98106112/04A RU98106112A RU2198876C2 RU 2198876 C2 RU2198876 C2 RU 2198876C2 RU 98106112/04 A RU98106112/04 A RU 98106112/04A RU 98106112 A RU98106112 A RU 98106112A RU 2198876 C2 RU2198876 C2 RU 2198876C2
Authority
RU
Russia
Prior art keywords
formula
alkyl
compounds
phenyl
compound
Prior art date
Application number
RU98106112/04A
Other languages
English (en)
Russian (ru)
Other versions
RU98106112A (ru
Inventor
Хайнер ГЛОМБИК (DE)
Хайнер Гломбик
Альфонс ЭНЗЕН (DE)
Альфонс ЭНЗЕН
Вернер КРАМЕР (DE)
Вернер Крамер
Карл-Хайнц БАРИНГХАУС (DE)
Карл-Хайнц Барингхаус
Original Assignee
Авентис Фарма Дойчланд Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1998102530 external-priority patent/DE19802530A1/de
Application filed by Авентис Фарма Дойчланд Гмбх filed Critical Авентис Фарма Дойчланд Гмбх
Publication of RU98106112A publication Critical patent/RU98106112A/ru
Application granted granted Critical
Publication of RU2198876C2 publication Critical patent/RU2198876C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Obesity (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
RU98106112/04A 1997-04-04 1998-04-03 Производные пропаноламина, способы их получения и средство на их основе RU2198876C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19713865 1997-04-04
DE19713865.9 1997-04-04
DE1998102530 DE19802530A1 (de) 1998-01-26 1998-01-26 Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE19802530.0 1998-01-26

Publications (2)

Publication Number Publication Date
RU98106112A RU98106112A (ru) 2000-01-27
RU2198876C2 true RU2198876C2 (ru) 2003-02-20

Family

ID=26035472

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98106112/04A RU2198876C2 (ru) 1997-04-04 1998-04-03 Производные пропаноламина, способы их получения и средство на их основе

Country Status (23)

Country Link
US (1) US5874451A (enExample)
EP (1) EP0869121B1 (enExample)
JP (1) JP4234805B2 (enExample)
KR (1) KR19980081055A (enExample)
CN (1) CN1185217C (enExample)
AR (1) AR011210A1 (enExample)
AT (1) ATE268758T1 (enExample)
AU (1) AU730228B2 (enExample)
BR (1) BR9801150A (enExample)
CA (1) CA2233925A1 (enExample)
CZ (1) CZ293758B6 (enExample)
DE (1) DE59811528D1 (enExample)
DK (1) DK0869121T3 (enExample)
ES (1) ES2223091T3 (enExample)
HU (1) HUP9800781A3 (enExample)
ID (1) ID20137A (enExample)
IL (1) IL123927A (enExample)
MY (1) MY114944A (enExample)
NZ (1) NZ330110A (enExample)
PL (1) PL325699A1 (enExample)
PT (1) PT869121E (enExample)
RU (1) RU2198876C2 (enExample)
TR (1) TR199800608A3 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19845402B4 (de) 1998-10-02 2005-04-07 Aventis Pharma Deutschland Gmbh Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE69919707T2 (de) 1998-06-19 2005-09-01 Chiron Corp., Emeryville Glycogen synthase kinase 3 inhibitoren
US7045519B2 (en) * 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
DE19845403B4 (de) 1998-10-02 2005-02-10 Aventis Pharma Deutschland Gmbh Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE19845406C2 (de) * 1998-10-02 2001-10-18 Aventis Pharma Gmbh Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE19845405C2 (de) 1998-10-02 2000-07-13 Aventis Pharma Gmbh Arylsubstituierte Propanolaminderivate und deren Verwendung
CA2431995A1 (en) 2000-12-21 2002-06-27 Aventis Pharma Deutschland Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
JP2005505538A (ja) * 2001-08-22 2005-02-24 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング アリール置換プロパノールアミン誘導体と他の活性成分との組み合わせ物およびその使用
EP1553075B1 (en) 2002-10-03 2013-08-14 Ono Pharmaceutical Co., Ltd. Lpa receptor antagonists
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
TW200521108A (en) 2003-12-19 2005-07-01 Ono Pharmaceutical Co Compounds having lysophosphatidic acid receptor(LPA)-antagonizing effect and their use
CN1869002A (zh) * 2005-05-27 2006-11-29 中国科学院上海药物研究所 一类非甾体雄激素受体调节剂、其制备方法和用途
PL2848610T3 (pl) * 2006-11-15 2018-01-31 Ym Biosciences Australia Pty Inhibitory aktywności kinazy
EP4137137A1 (en) 2010-05-26 2023-02-22 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
EA038594B1 (ru) 2011-10-28 2021-09-21 Шайр Хьюман Дженетик Терапис, Инк. Ингибиторы рециркуляции желчных кислот для лечения гиперхолемии и холестатического заболевания печени
JP6217938B2 (ja) 2011-10-28 2017-10-25 ルメナ ファーマシューティカルズ エルエルシー 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤
KR20160002773A (ko) 2013-03-15 2016-01-08 루메나 파마수티컬즈, 인코포레이티드 원발성 담관염 및 염증성 장 질환 치료용 담즙산 재순환 억제제
AU2014229050A1 (en) 2013-03-15 2015-10-22 Lumena Pharmaceuticals Llc Bile acid recycling inhibitors for treatment of Barrett's esophagus and gastroesophageal reflux disease
CN105553262B (zh) * 2015-08-24 2018-02-16 苏州瑞铬优电子科技有限公司 一种提高dc/dc升压变换器转换效率的方法
EP4424363B1 (en) 2019-02-12 2026-04-29 Mirum Pharmaceuticals, Inc. Methods for increasing growth in pediatric subjects having cholestatic liver disease

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0345591A1 (de) * 1988-06-10 1989-12-13 F. Hoffmann-La Roche Ag Propanolaminderivate
RU2026290C1 (ru) * 1990-12-14 1995-01-09 Байер Аг 3r,5s-(+)-7-[4-(4-фторфенил)-2,6- диизопропил-5-метоксиметил-пирид-3-ил]-3,5- диоксигептеновая кислота в эритро-(e)-конфигурации в виде физиологически переносимой соли металла в качестве ингибитора биосинтеза холестерина

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250524A (en) * 1990-12-06 1993-10-05 Hoechst Aktiengesellschaft Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals
GB9203347D0 (en) * 1992-02-17 1992-04-01 Wellcome Found Hypolipidaemic compounds
ES2098570T3 (es) * 1992-02-22 1997-05-01 Hoechst Ag Amidas de un acido 4-amino-2-ureido-pirimidina-5-carboxilico, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su utilizacion.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0345591A1 (de) * 1988-06-10 1989-12-13 F. Hoffmann-La Roche Ag Propanolaminderivate
RU2026290C1 (ru) * 1990-12-14 1995-01-09 Байер Аг 3r,5s-(+)-7-[4-(4-фторфенил)-2,6- диизопропил-5-метоксиметил-пирид-3-ил]-3,5- диоксигептеновая кислота в эритро-(e)-конфигурации в виде физиологически переносимой соли металла в качестве ингибитора биосинтеза холестерина

Also Published As

Publication number Publication date
EP0869121A1 (de) 1998-10-07
AR011210A1 (es) 2000-08-02
CA2233925A1 (en) 1998-10-04
NZ330110A (en) 1999-03-29
HK1015789A1 (en) 1999-10-22
AU730228B2 (en) 2001-03-01
KR19980081055A (ko) 1998-11-25
TR199800608A2 (en) 1998-10-21
MY114944A (en) 2003-02-28
PL325699A1 (en) 1998-10-12
CZ102598A3 (cs) 1998-10-14
JPH10287651A (ja) 1998-10-27
ID20137A (id) 1998-10-08
CN1185217C (zh) 2005-01-19
IL123927A (en) 2001-01-28
HUP9800781A2 (hu) 1999-06-28
TR199800608A3 (tr) 1998-10-21
DE59811528D1 (de) 2004-07-15
HUP9800781A3 (en) 1999-07-28
ES2223091T3 (es) 2005-02-16
HU9800781D0 (en) 1998-05-28
CZ293758B6 (cs) 2004-07-14
EP0869121B1 (de) 2004-06-09
AU6062498A (en) 1998-10-08
US5874451A (en) 1999-02-23
DK0869121T3 (da) 2004-09-20
PT869121E (pt) 2004-10-29
CN1199731A (zh) 1998-11-25
JP4234805B2 (ja) 2009-03-04
ATE268758T1 (de) 2004-06-15
BR9801150A (pt) 2000-03-21

Similar Documents

Publication Publication Date Title
JP3794618B2 (ja) アリール置換プロパノールアミン誘導体、その製造法、その化合物を含有する医薬およびその使用
JP4234805B2 (ja) プロパノールアミン誘導体、それらの製法、それらを含有する薬剤およびそれらの使用
WO1997012860A1 (en) Novel heterocyclic derivatives and medicinal use thereof
JPH08325263A (ja) 新規２−アミノ−３−フェニルプロピオン酸誘導体
EP0350878B1 (en) Conjugated gamma-oxybutenolide compounds for treating ulcer
RU2234512C2 (ru) Соединенные с желчными кислотами производные пропаноламина, лекарственное средство
RU2247125C2 (ru) Конъюгаты 4-бензиламинохинолинов с желчной кислотой и их гетероаналоги, способ их получения и лекарственные средства на основе этих соединений
CN1128999A (zh) 杂环化合物
JP3498853B2 (ja) ビフェニル誘導体
JPH083163A (ja) 縮合ピリジン誘導体
JPH06104658B2 (ja) ピロールカルボン酸誘導体
WO2003045953A1 (en) Crystals of taxane derivative and process for their production
JP2790335B2 (ja) 共役γ―オキシブテノライド化合物およびこれを有効成分とする抗潰瘍剤
JPH0211592A (ja) 光学活性なジヒドロピリジンホスホン酸エステル
JPH01199962A (ja) ピペリジン化合物
MXPA98002623A (en) Derivatives of propanolamine, procedures for its preparation, medications that contain these compounds and its use
JP2510893B2 (ja) ナフチルスルホニルアルキルカルボン酸誘導体
JPH05125038A (ja) フエノキシアルカン酸誘導体及びその製法
JPH06329626A (ja) ピロリジン誘導体
JP4011780B2 (ja) ジヒドロキノリン誘導体
JP2686876B2 (ja) 新規なコハク酸誘導体
JPH0672867A (ja) 抗脂血剤
JPH0156066B2 (enExample)
JPWO1997031900A1 (ja) イミダゾール誘導体および血管壁肥厚抑制剤
JP2009517425A (ja) 複素芳香族スルホンアミドプロドラッグ

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner
MM4A The patent is invalid due to non-payment of fees

Effective date: 20060404